{"transactions":[{"id":1033793,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T16:33:39.000Z","date":"2025-09-19","kind":"sale","planned":false,"acquired":false,"shares":532870,"price":1.4014,"value":746764.018,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.40 to $1.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"VV I GP\") and VV I GP is the sole general partner of VV I. Each of VV I GP-GP and VV I GP may be deemed to share voting, investment and dispositive power over the shares held by VV I and disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-213445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000119312525213445/ownership.xml","form_type":"4"}},{"id":1033792,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T16:33:39.000Z","date":"2025-09-19","kind":"sale","planned":false,"acquired":false,"shares":2370533,"price":1.4014,"value":3322064.9462,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.40 to $1.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-213445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000119312525213445/ownership.xml","form_type":"4"}},{"id":1036384,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-18T18:49:18.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":228791,"price":1.4418,"value":329870.8638,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.43 to $1.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"VV I GP\") and VV I GP is the sole general partner of VV I. Each of VV I GP-GP and VV I GP may be deemed to share voting, investment and dispositive power over the shares held by VV I and disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":532870,"source":{"system":"sec-edgar","filing":"0001193125-25-207677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000119312525207677/ownership.xml","form_type":"4"}},{"id":1036383,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-18T18:49:18.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":366111,"price":1.4418,"value":527858.8398,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.43 to $1.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":2370533,"source":{"system":"sec-edgar","filing":"0001193125-25-207677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000119312525207677/ownership.xml","form_type":"4"}},{"id":1036382,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-18T18:49:18.000Z","date":"2025-09-17","kind":"sale","planned":false,"acquired":false,"shares":226726,"price":1.4892,"value":337640.3592,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.47 to $1.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"VV I GP\") and VV I GP is the sole general partner of VV I. Each of VV I GP-GP and VV I GP may be deemed to share voting, investment and dispositive power over the shares held by VV I and disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":761661,"source":{"system":"sec-edgar","filing":"0001193125-25-207677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000119312525207677/ownership.xml","form_type":"4"}},{"id":1036381,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-18T18:49:18.000Z","date":"2025-09-17","kind":"sale","planned":false,"acquired":false,"shares":362806,"price":1.4892,"value":540290.6952,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.47 to $1.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":2736644,"source":{"system":"sec-edgar","filing":"0001193125-25-207677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000119312525207677/ownership.xml","form_type":"4"}},{"id":1036380,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-18T18:49:18.000Z","date":"2025-09-16","kind":"sale","planned":false,"acquired":false,"shares":192293,"price":1.5332,"value":294823.6276,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.50 to $1.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"VV I GP\") and VV I GP is the sole general partner of VV I. Each of VV I GP-GP and VV I GP may be deemed to share voting, investment and dispositive power over the shares held by VV I and disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":988387,"source":{"system":"sec-edgar","filing":"0001193125-25-207677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000119312525207677/ownership.xml","form_type":"4"}},{"id":1036379,"issuer":{"id":73047,"kind":"organization","name":"LAVA Therapeutics NV","symbol":"LVTX"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-18T18:49:18.000Z","date":"2025-09-16","kind":"sale","planned":false,"acquired":false,"shares":307707,"price":1.5332,"value":471776.3724,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.50 to $1.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":3099450,"source":{"system":"sec-edgar","filing":"0001193125-25-207677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000119312525207677/ownership.xml","form_type":"4"}},{"id":1379399,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-29","kind":"sale","planned":false,"acquired":false,"shares":15600,"price":9.4098,"value":146792.88,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $9.33 to $9.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (19) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage I\"). Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP. Each of Versant Vantage I GP-GP and Versant Vantage I GP may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1573453,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379398,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-29","kind":"sale","planned":false,"acquired":false,"shares":52305,"price":9.0815,"value":475007.8575,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $8.36 to $9.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (18) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage I\"). Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP. Each of Versant Vantage I GP-GP and Versant Vantage I GP may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1589053,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379397,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-28","kind":"other","planned":false,"acquired":false,"shares":5454,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F17","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP-GP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Shares held by Versant Vantage I GP-GP."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379396,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-28","kind":"other","planned":false,"acquired":true,"shares":5454,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F15","text":"Represents a change in the form of ownership of Versant Vantage I GP-GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Shares held by Versant Vantage I GP-GP."}],"balance_after":5454,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379395,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-28","kind":"other","planned":false,"acquired":false,"shares":5499,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F14","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Shares held by Versant Vantage I GP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379394,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-28","kind":"other","planned":false,"acquired":true,"shares":5499,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F12","text":"Represents a change in the form of ownership of Versant Vantage I GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Shares held by Versant Vantage I GP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein."}],"balance_after":5499,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379393,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-28","kind":"other","planned":false,"acquired":false,"shares":366590,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage I\"). Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP. Each of Versant Vantage I GP-GP and Versant Vantage I GP may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1641358,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379392,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-28","kind":"other","planned":false,"acquired":false,"shares":17595,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP-GP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by Versant Ventures VI GP-GP."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379391,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-28","kind":"other","planned":false,"acquired":true,"shares":17595,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a change in the form of ownership of Versant Ventures VI GP-GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VI GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by Versant Ventures VI GP-GP."}],"balance_after":17595,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379390,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-28","kind":"other","planned":false,"acquired":false,"shares":20397,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Ventures VI GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379389,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-28","kind":"other","planned":false,"acquired":true,"shares":20397,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a change in the form of ownership of Versant Ventures VI GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Ventures VI GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein."}],"balance_after":20397,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379388,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-28","kind":"other","planned":false,"acquired":false,"shares":1019867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. (\"Versant VI\") to its partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Versant Ventures VI GP-GP and Versant Ventures VI GP may be deemed to share voting, investment and dispositive power over the shares held by Versant VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":4079469,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1379387,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T16:35:43.000Z","date":"2024-10-28","kind":"sale","planned":false,"acquired":false,"shares":89990,"price":9.6593,"value":869240.407,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $9.50 to $10.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage I\"). Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP. Each of Versant Vantage I GP-GP and Versant Vantage I GP may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":2007948,"source":{"system":"sec-edgar","filing":"0000950170-24-119051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024119051/ownership.xml","form_type":"4"}},{"id":1400176,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-24T16:40:59.000Z","date":"2024-09-20","kind":"sale","planned":false,"acquired":false,"shares":1132566,"price":6.5296,"value":7395202.9536,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $6.30 to $6.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Versant VI GP-GP and Versant VI GP may be deemed to share voting, investment and dispositive power over the shares held by Versant VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":5099336,"source":{"system":"sec-edgar","filing":"0000950170-24-109112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024109112/ownership.xml","form_type":"4"}},{"id":1407725,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T18:44:19.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":9269,"price":6.1603,"value":57099.8207,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $6.02 to $6.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Versant VI GP-GP and Versant VI GP may be deemed to share voting, investment and dispositive power over the shares held by Versant VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":6231902,"source":{"system":"sec-edgar","filing":"0000950170-24-106532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024106532/ownership.xml","form_type":"4"}},{"id":1407724,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T18:44:19.000Z","date":"2024-09-12","kind":"sale","planned":false,"acquired":false,"shares":16047,"price":6.0017,"value":96309.2799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $6.00 to $6.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Versant VI GP-GP and Versant VI GP may be deemed to share voting, investment and dispositive power over the shares held by Versant VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":6241171,"source":{"system":"sec-edgar","filing":"0000950170-24-106532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024106532/ownership.xml","form_type":"4"}},{"id":1407723,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T18:44:19.000Z","date":"2024-09-11","kind":"sale","planned":false,"acquired":false,"shares":541897,"price":6,"value":3251382.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $6.00 to $6.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Versant VI GP-GP and Versant VI GP may be deemed to share voting, investment and dispositive power over the shares held by Versant VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":6257218,"source":{"system":"sec-edgar","filing":"0000950170-24-106532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000095017024106532/ownership.xml","form_type":"4"}},{"id":1543220,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":275769,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP, L.P. (\"VV I GP\") is the general partner of VV I, and Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein."}],"balance_after":710494,"derivative":{"underlying":"Class B Common Stock","underlying_shares":275769},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543219,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":689,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":12123,"derivative":{"underlying":"Class B Common Stock","underlying_shares":689},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543218,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":110187,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":1934776,"derivative":{"underlying":"Class B Common Stock","underlying_shares":110187},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543217,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":317988,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The shares are held directly by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP, L.P. (\"VV VI GP\") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC (\"VV VI GP-GP\") is the general partner of VV VI GP. Each of VV VI GP-GP and VV VI GP disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein."}],"balance_after":1741107,"derivative":{"underlying":"Class B Common Stock","underlying_shares":317988},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543216,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":434725,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP, L.P. (\"VV I GP\") is the general partner of VV I, and Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein."}],"balance_after":434725,"derivative":{"underlying":"Class B Common Stock","underlying_shares":434725},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543215,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":2182,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":11434,"derivative":{"underlying":"Class B Common Stock","underlying_shares":2182},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543214,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":348143,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":1824589,"derivative":{"underlying":"Class B Common Stock","underlying_shares":348143},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543213,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":1423119,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The shares are held directly by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP, L.P. (\"VV VI GP\") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC (\"VV VI GP-GP\") is the general partner of VV VI GP. Each of VV VI GP-GP and VV VI GP disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein."}],"balance_after":1423119,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1423119},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543212,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":9252,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":9252,"derivative":{"underlying":"Class B Common Stock","underlying_shares":9252},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543211,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":1476446,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":1476446,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1476446},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543210,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":57565,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP, L.P. (\"VV I GP\") is the general partner of VV I, and Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":57565},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543209,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":145,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":145},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543208,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":22312,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":22312},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543207,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":90747,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP, L.P. (\"VV I GP\") is the general partner of VV I, and Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":90747},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543206,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":455,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":455},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543205,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":70498,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":70498},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543204,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":1931,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1931},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543203,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":298975,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":298975},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543202,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":148312,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP, L.P. (\"VV I GP\") is the general partner of VV I, and Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein."}],"balance_after":148312,"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543201,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":2531,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":2531,"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543200,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":391785,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":391785,"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":2068178,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T18:11:53.000Z","date":"2023-01-03","kind":"other","acquired":false,"shares":1003658,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 7, 2022, among the Issuer, Iris Purchaser Inc. (\"Purchaser\"), a wholly owned subsidiary of Viatris, Inc. (\"Viatris\"), and Viatris, Purchaser commenced a tender offer (the \"Offer\") to purchase all the outstanding common stock of the Issuer for the Per Share Price (as defined below). On January 3, 2023, the Offer consummated, after which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Viatris (the \"Merger\"). At the consummation of the Offer and the Merger, respectively, (i) Purchaser purchased all shares of Issuer's common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Per Share Price and (ii) each share of the Issuer's common stock that was issued and outstanding immediately prior to the effective time of the Merger (the \"Effective Time\")(continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(other than shares that were held (a) by the Issuer (including any treasury shares) or by Viatris or Purchaser or any other direct or indirect wholly owned subsidiary of Viatris or (b) by stockholders of the Issuer who had properly exercised and perfected, and not withdrawn or otherwise lost, their appraisal rights under the Delaware General Corporate Law) was cancelled and converted into the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved (the \"Milestone Payment\" and together with the Cash Amount, the \"Per Share Price\") pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage\"). Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") and Versant Vantage I GP is the sole general Partner of Versant Vantage. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage. Each of Versant Vantage I GP-GP, Versant Vantage I GP, and Clare Ozawa disclaims beneficial ownership of the shares held by Versant Vantage, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924323000677/doc4.xml","form_type":"4"}},{"id":2068177,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T18:11:53.000Z","date":"2023-01-03","kind":"other","acquired":false,"shares":2465,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 7, 2022, among the Issuer, Iris Purchaser Inc. (\"Purchaser\"), a wholly owned subsidiary of Viatris, Inc. (\"Viatris\"), and Viatris, Purchaser commenced a tender offer (the \"Offer\") to purchase all the outstanding common stock of the Issuer for the Per Share Price (as defined below). On January 3, 2023, the Offer consummated, after which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Viatris (the \"Merger\"). At the consummation of the Offer and the Merger, respectively, (i) Purchaser purchased all shares of Issuer's common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Per Share Price and (ii) each share of the Issuer's common stock that was issued and outstanding immediately prior to the effective time of the Merger (the \"Effective Time\")(continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(other than shares that were held (a) by the Issuer (including any treasury shares) or by Viatris or Purchaser or any other direct or indirect wholly owned subsidiary of Viatris or (b) by stockholders of the Issuer who had properly exercised and perfected, and not withdrawn or otherwise lost, their appraisal rights under the Delaware General Corporate Law) was cancelled and converted into the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved (the \"Milestone Payment\" and together with the Cash Amount, the \"Per Share Price\") pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\"). Versant Ventures IV is the sole general partner of Versant Side Fund IV. Versant Ventures IV disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of its pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924323000677/doc4.xml","form_type":"4"}},{"id":2068176,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T18:11:53.000Z","date":"2023-01-03","kind":"other","acquired":false,"shares":414607,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 7, 2022, among the Issuer, Iris Purchaser Inc. (\"Purchaser\"), a wholly owned subsidiary of Viatris, Inc. (\"Viatris\"), and Viatris, Purchaser commenced a tender offer (the \"Offer\") to purchase all the outstanding common stock of the Issuer for the Per Share Price (as defined below). On January 3, 2023, the Offer consummated, after which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Viatris (the \"Merger\"). At the consummation of the Offer and the Merger, respectively, (i) Purchaser purchased all shares of Issuer's common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Per Share Price and (ii) each share of the Issuer's common stock that was issued and outstanding immediately prior to the effective time of the Merger (the \"Effective Time\")(continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(other than shares that were held (a) by the Issuer (including any treasury shares) or by Viatris or Purchaser or any other direct or indirect wholly owned subsidiary of Viatris or (b) by stockholders of the Issuer who had properly exercised and perfected, and not withdrawn or otherwise lost, their appraisal rights under the Delaware General Corporate Law) was cancelled and converted into the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved (the \"Milestone Payment\" and together with the Cash Amount, the \"Per Share Price\") pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Venture Capital IV, L.P. (\"Versant IV\"). Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. Versant Ventures IV disclaims beneficial ownership of the shares held by Versant IV, except to the extent of its pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924323000677/doc4.xml","form_type":"4"}},{"id":2068175,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T18:11:53.000Z","date":"2023-01-03","kind":"other","acquired":false,"shares":2236888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 7, 2022, among the Issuer, Iris Purchaser Inc. (\"Purchaser\"), a wholly owned subsidiary of Viatris, Inc. (\"Viatris\"), and Viatris, Purchaser commenced a tender offer (the \"Offer\") to purchase all the outstanding common stock of the Issuer for the Per Share Price (as defined below). On January 3, 2023, the Offer consummated, after which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Viatris (the \"Merger\"). At the consummation of the Offer and the Merger, respectively, (i) Purchaser purchased all shares of Issuer's common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Per Share Price and (ii) each share of the Issuer's common stock that was issued and outstanding immediately prior to the effective time of the Merger (the \"Effective Time\")(continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(other than shares that were held (a) by the Issuer (including any treasury shares) or by Viatris or Purchaser or any other direct or indirect wholly owned subsidiary of Viatris or (b) by stockholders of the Issuer who had properly exercised and perfected, and not withdrawn or otherwise lost, their appraisal rights under the Delaware General Corporate Law) was cancelled and converted into the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved (the \"Milestone Payment\" and together with the Cash Amount, the \"Per Share Price\") pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Shares held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") and Versant Ventures VI GP is the sole general partner of Versant VI. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP and Clare Ozawa disclaims beneficial ownership of the shares held by Versant VI, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924323000677/doc4.xml","form_type":"4"}},{"id":2240347,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":10099,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F18","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V (Canada), to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F17","text":"Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240346,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-06","kind":"other","acquired":true,"shares":10099,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents a change in the form of ownership of VV V (Canada) by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V (Canada)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F17","text":"Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":10099,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240345,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":46753,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F15","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VVC V (Canada) to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Venture Capital V (Canada) LP (\"VVC V (Canada)\"). Versant Ventures V (Canada) GP-GP, Inc. (\"VV V (Canada) GP\") is the sole general partner of Versant Ventures V (Canada), L.P. (\"VV V (Canada)\") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":64731,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240344,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":141103,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F14","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240343,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-06","kind":"other","acquired":true,"shares":4419,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VOAF I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":141103,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240342,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":20454,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F12","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VOAF I to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Versant Ophthalmic Affiliates Fund I, L.P. (\"VOAF I\"). VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":28322,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240341,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-06","kind":"other","acquired":true,"shares":3992,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VAF V."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":136684,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240340,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":18478,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VAF V to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Affiliates Fund V, L.P. (\"VAF V\"). VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":25587,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240339,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-06","kind":"other","acquired":true,"shares":132692,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":132692,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240338,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":614315,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VVC V to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Venture Capital V, L.P. (\"VVC V\"). Versant Ventures V, LLC (\"VV V\") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":850560,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240337,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":33395,"price":12.2517,"value":409145.5215,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Venture Capital V (Canada) LP (\"VVC V (Canada)\"). Versant Ventures V (Canada) GP-GP, Inc. (\"VV V (Canada) GP\") is the sole general partner of Versant Ventures V (Canada), L.P. (\"VV V (Canada)\") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":111484,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240336,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":14611,"price":12.2517,"value":179009.5887,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Versant Ophthalmic Affiliates Fund I, L.P. (\"VOAF I\"). VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":48776,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240335,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":13199,"price":12.2517,"value":161710.1883,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Affiliates Fund V, L.P. (\"VAF V\"). VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":44065,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240334,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":438795,"price":12.2517,"value":5375984.7015,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Venture Capital V, L.P. (\"VVC V\"). Versant Ventures V, LLC (\"VV V\") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":1464875,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2240333,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:37:05.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":250000,"price":12.2517,"value":3062925.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":2344451,"source":{"system":"sec-edgar","filing":"0000899243-22-021350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021350/doc4.xml","form_type":"4"}},{"id":2440200,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T16:20:37.000Z","date":"2022-01-05","kind":"other","acquired":false,"shares":1261,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":2465,"source":{"system":"sec-edgar","filing":"0000899243-22-001360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924322001360/doc4.xml","form_type":"4"}},{"id":2440199,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T16:20:37.000Z","date":"2022-01-05","kind":"other","acquired":false,"shares":51556,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-001360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924322001360/doc4.xml","form_type":"4"}},{"id":2440198,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T16:20:37.000Z","date":"2022-01-05","kind":"other","acquired":true,"shares":51556,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures IV by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":51556,"source":{"system":"sec-edgar","filing":"0000899243-22-001360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924322001360/doc4.xml","form_type":"4"}},{"id":2440197,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T16:20:37.000Z","date":"2022-01-05","kind":"other","acquired":false,"shares":200213,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. (\"Versant IV\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":414607,"source":{"system":"sec-edgar","filing":"0000899243-22-001360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924322001360/doc4.xml","form_type":"4"}},{"id":2459687,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T16:40:01.000Z","date":"2021-12-21","kind":"other","acquired":false,"shares":1261,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":3726,"source":{"system":"sec-edgar","filing":"0000899243-21-049594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321049594/doc4.xml","form_type":"4"}},{"id":2459686,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T16:40:01.000Z","date":"2021-12-21","kind":"other","acquired":false,"shares":51556,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-049594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321049594/doc4.xml","form_type":"4"}},{"id":2459685,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T16:40:01.000Z","date":"2021-12-21","kind":"other","acquired":true,"shares":51556,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures IV by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":51556,"source":{"system":"sec-edgar","filing":"0000899243-21-049594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321049594/doc4.xml","form_type":"4"}},{"id":2459684,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T16:40:01.000Z","date":"2021-12-21","kind":"other","acquired":false,"shares":200213,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. (\"Versant IV\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":614820,"source":{"system":"sec-edgar","filing":"0000899243-21-049594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321049594/doc4.xml","form_type":"4"}},{"id":2538254,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T16:38:25.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":1531,"price":15.0939,"value":23108.7609,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $15.00 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4987,"source":{"system":"sec-edgar","filing":"0000899243-21-040777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321040777/doc4.xml","form_type":"4"}},{"id":2538253,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T16:38:25.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":242943,"price":15.0939,"value":3666957.3477,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $15.00 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":815033,"source":{"system":"sec-edgar","filing":"0000899243-21-040777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321040777/doc4.xml","form_type":"4"}},{"id":2538252,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T16:38:25.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":1912,"price":14.6327,"value":27977.7224,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $14.00 to $14.995, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":6518,"source":{"system":"sec-edgar","filing":"0000899243-21-040777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321040777/doc4.xml","form_type":"4"}},{"id":2538251,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T16:38:25.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":303614,"price":14.6327,"value":4442692.5778,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $14.00 to $14.995, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1057976,"source":{"system":"sec-edgar","filing":"0000899243-21-040777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321040777/doc4.xml","form_type":"4"}},{"id":2610174,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-08-09T20:42:27.000Z","date":"2021-08-05","kind":"other","acquired":false,"shares":2260,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP-GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-032172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321032172/doc4.xml","form_type":"4"}},{"id":2610173,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-08-09T20:42:27.000Z","date":"2021-08-05","kind":"other","acquired":true,"shares":2260,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of VV I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":2260,"source":{"system":"sec-edgar","filing":"0000899243-21-032172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321032172/doc4.xml","form_type":"4"}},{"id":2610172,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-08-09T20:42:27.000Z","date":"2021-08-05","kind":"other","acquired":false,"shares":2279,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-032172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321032172/doc4.xml","form_type":"4"}},{"id":2610171,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-08-09T20:42:27.000Z","date":"2021-08-05","kind":"other","acquired":true,"shares":2279,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of VV I GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":2279,"source":{"system":"sec-edgar","filing":"0000899243-21-032172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321032172/doc4.xml","form_type":"4"}},{"id":2610170,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-08-09T20:42:27.000Z","date":"2021-08-05","kind":"other","acquired":false,"shares":152071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I, L.P. (\"VV I\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by VV I. Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"VV I GP\") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":231211,"source":{"system":"sec-edgar","filing":"0000899243-21-032172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321032172/doc4.xml","form_type":"4"}},{"id":2650277,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C convertible preferred stock","published_at":"2021-06-30T17:00:29.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":2699328,"ownership":{"direct":false,"nature":"By Versant Vantage I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage I\"). Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I. Each of Versant Vantage I GP, Versant Vantage I GP-GP and Bradley J. Bolzon disclaim beneficial ownership of such securities, except to the extent of their respective pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":764573},"source":{"system":"sec-edgar","filing":"0000899243-21-026766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321026766/doc4.xml","form_type":"4"}},{"id":2650276,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B convertible preferred stock","published_at":"2021-06-30T17:00:29.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":4150000,"ownership":{"direct":false,"nature":"By Versant Vantage I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage I\"). Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I. Each of Versant Vantage I GP, Versant Vantage I GP-GP and Bradley J. Bolzon disclaim beneficial ownership of such securities, except to the extent of their respective pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1175470},"source":{"system":"sec-edgar","filing":"0000899243-21-026766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321026766/doc4.xml","form_type":"4"}},{"id":2650275,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B convertible preferred stock","published_at":"2021-06-30T17:00:29.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":3000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP GP\") is the general partner of Versant Ventures VI GP.  Bradley J. Bolzon, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP, Versant Ventures VI GP-GP and Bradley J. Bolzon disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":849738},"source":{"system":"sec-edgar","filing":"0000899243-21-026766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321026766/doc4.xml","form_type":"4"}},{"id":2650274,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A convertible preferred stock","published_at":"2021-06-30T17:00:29.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":20004280,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP GP\") is the general partner of Versant Ventures VI GP.  Bradley J. Bolzon, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP, Versant Ventures VI GP-GP and Bradley J. Bolzon disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5666131},"source":{"system":"sec-edgar","filing":"0000899243-21-026766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321026766/doc4.xml","form_type":"4"}},{"id":2650273,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T17:00:29.000Z","date":"2021-06-28","kind":"purchase","acquired":true,"shares":157895,"price":19,"value":3000005.0,"ownership":{"direct":false,"nature":"By Versant Vantage I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage I\"). Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I. Each of Versant Vantage I GP, Versant Vantage I GP-GP and Bradley J. Bolzon disclaim beneficial ownership of such securities, except to the extent of their respective pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":2097938,"source":{"system":"sec-edgar","filing":"0000899243-21-026766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321026766/doc4.xml","form_type":"4"}},{"id":2650272,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T17:00:29.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":1940043,"ownership":{"direct":false,"nature":"By Versant Vantage I, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage I\"). Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I. Each of Versant Vantage I GP, Versant Vantage I GP-GP and Bradley J. Bolzon disclaim beneficial ownership of such securities, except to the extent of their respective pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1940043,"source":{"system":"sec-edgar","filing":"0000899243-21-026766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321026766/doc4.xml","form_type":"4"}},{"id":2650271,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T17:00:29.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":6515869,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP GP\") is the general partner of Versant Ventures VI GP.  Bradley J. Bolzon, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP, Versant Ventures VI GP-GP and Bradley J. Bolzon disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports"}],"balance_after":6799115,"source":{"system":"sec-edgar","filing":"0000899243-21-026766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321026766/doc4.xml","form_type":"4"}},{"id":2683585,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-03T20:32:11.000Z","date":"2021-06-01","kind":"other","acquired":false,"shares":1119,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP-GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-021800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321021800/doc4.xml","form_type":"4"}},{"id":2683584,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-03T20:32:11.000Z","date":"2021-06-01","kind":"other","acquired":true,"shares":1119,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of VV I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":1119,"source":{"system":"sec-edgar","filing":"0000899243-21-021800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321021800/doc4.xml","form_type":"4"}},{"id":2683583,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-03T20:32:11.000Z","date":"2021-06-01","kind":"other","acquired":false,"shares":1128,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-021800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321021800/doc4.xml","form_type":"4"}},{"id":2683582,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-03T20:32:11.000Z","date":"2021-06-01","kind":"other","acquired":true,"shares":1128,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of VV I GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":1128,"source":{"system":"sec-edgar","filing":"0000899243-21-021800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321021800/doc4.xml","form_type":"4"}},{"id":2683581,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-03T20:32:11.000Z","date":"2021-06-01","kind":"other","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I, L.P. (\"VV I\"), to its partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by VV I. Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"VV I GP\") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":383282,"source":{"system":"sec-edgar","filing":"0000899243-21-021800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321021800/doc4.xml","form_type":"4"}},{"id":2712517,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T16:45:05.000Z","date":"2021-05-12","kind":"other","acquired":false,"shares":2018,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\") to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":8430,"source":{"system":"sec-edgar","filing":"0000899243-21-019515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321019515/doc4.xml","form_type":"4"}},{"id":2712516,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T16:45:05.000Z","date":"2021-05-12","kind":"other","acquired":false,"shares":82486,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-019515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321019515/doc4.xml","form_type":"4"}},{"id":2712515,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T16:45:05.000Z","date":"2021-05-12","kind":"other","acquired":true,"shares":82486,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures IV by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":82486,"source":{"system":"sec-edgar","filing":"0000899243-21-019515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321019515/doc4.xml","form_type":"4"}},{"id":2712514,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T16:45:05.000Z","date":"2021-05-12","kind":"other","acquired":false,"shares":320340,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. (\"Versant IV\") to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1361590,"source":{"system":"sec-edgar","filing":"0000899243-21-019515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321019515/doc4.xml","form_type":"4"}},{"id":2723377,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:27:48.000Z","date":"2021-05-05","kind":"other","acquired":false,"shares":3473,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V (Canada), to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-018678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018678/doc4.xml","form_type":"4"}},{"id":2723376,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":1,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":2,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":3,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:27:48.000Z","date":"2021-05-05","kind":"other","acquired":true,"shares":3473,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F14","text":"Represents a change in the form of ownership of VV V (Canada) by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V (Canada)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":3473,"source":{"system":"sec-edgar","filing":"0000899243-21-018678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018678/doc4.xml","form_type":"4"}}],"next_cursor":"2021-05-07T20:27:48.000000Z,2723376"}